Avalo Therapeutics, Inc. (AVTX)

22.98 +1.17 (+5.36%) USD  |  NASDAQ  |  May 07, 16:00
22.84 -0.14 (-0.61%) After-Hours: 20:00
More

Avalo Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for AVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade